Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Radiation Therapy
Treatment for Larynx cancer
Typical Dosage: 60-70 Gy over 6-7 weeks
Effectiveness
80%
Safety Score
25%
Clinical Trials
265
Participants
150K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
25
DangerousModerateSafe
Treatment Details
Dosage Range
60-70 Gy over 6-7 weeks
Time to Effect
Weeks to months
Treatment Duration
5-7 weeks
Evidence Quality
HIGHConfidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$5,000
Side Effect Mgmt:$3,000
Total Annual:$40,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$85,000/QALY
QALYs Gained
2.5
Outcome-Based Costs
Cost per Responder
$57,143
Cost per Remission
$66,667
Radiation Therapy Outcomes
for Larynx cancer
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+70%
Remission Rate
+60%
Common Side Effects
Dysphagia (difficulty swallowing)
+70%
Mucositis
+60%
Skin reactions (redness, peeling)
+85%
Voice changes (hoarseness)
+75%
Xerostomia (dry mouth)
+80%
Fatigue
+70%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
5 active trials recruiting for Radiation Therapy in Larynx cancer
Phase II Trial Evaluating Elimination of Radiation Therapy
NCT00593840ACTIVE NOT RECRUITINGPHASE2
74 participants
INTERVENTIONAL
St Louis, United States
Started: Apr 11, 2007
Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer
NCT06039631RECRUITINGPHASE2
82 participants
INTERVENTIONAL
Shanghai, China
Started: Aug 22, 2023
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
NCT03529422ACTIVE NOT RECRUITINGPHASE2
18 participants
INTERVENTIONAL
Birmingham, United States +2 more
Started: Oct 7, 2019
VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
NCT04057209RECRUITINGNA
34 participants
INTERVENTIONAL
Paris, France +3 more
Started: Nov 20, 2019
Precision Medicine: MRI-Guided Stereotactic Ablative Radiotherapy (MRI-SABR) for Early-Stage Glottic Laryngeal Cancer
NCT07391345RECRUITINGNA
105 participants
INTERVENTIONAL
Kaunas, Lithuania
Started: Sep 1, 2024
Completed Clinical Trials
7 completed trials for Radiation Therapy in Larynx cancer
Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer
NCT03548285COMPLETEDNA
25 participants
INTERVENTIONAL
Dallas, United States
Started: May 15, 2018
Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients
NCT00026975COMPLETEDPHASE2
150 participants
INTERVENTIONAL
Philadelphia, United States
Started: Sep 1, 2000
Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia
NCT02198131COMPLETEDNA
9 participants
INTERVENTIONAL
Winston-Salem, United States
Started: Oct 1, 2009
Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
NCT00002839COMPLETEDPHASE3
564 participants
INTERVENTIONAL
Antwerp, Belgium +19 more
Started: Jul 1, 1996
Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx
NCT00243113COMPLETEDPHASE2
50 participants
INTERVENTIONAL
Nagoya, Japan +8 more
Started: Jun 1, 2004
Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer
NCT03109873COMPLETEDEARLY_PHASE1
9 participants
INTERVENTIONAL
Philadelphia, United States
Started: Jan 5, 2017
A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN
NCT02126969COMPLETEDPHASE2
45 participants
INTERVENTIONAL
Lexington, United States
Started: Oct 1, 2014
Showing 20 of 271 total trials